Insulin aspart, recombinant Subcutaneous and Xpect-AT
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Xpect-AT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: carbetapentane / guaifenesin
Brand name: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Xpect-PE
- Insulin aspart, recombinant Subcutaneous-Xpovio
- Insulin aspart, recombinant Subcutaneous-Xpovio (100 MG Once Weekly)
- Insulin aspart, recombinant Subcutaneous-Xpovio (60 MG Once Weekly)
- Insulin aspart, recombinant Subcutaneous-Xpovio (80 MG Once Weekly)
- Insulin aspart, recombinant Subcutaneous-Xpovio (80 MG Twice Weekly)
- Xpect-AT-Insulin degludec
- Xpect-AT-Insulin Degludec (U-100) Prefilled Pens
- Xpect-AT-Insulin Degludec (U-100) Vials
- Xpect-AT-Insulin Degludec (U-200) Prefilled Pens
- Xpect-AT-Insulin degludec and liraglutide
- Xpect-AT-Insulin degludec and liraglutide Subcutaneous